Plasma protein thiols and total antioxidant power in pediatric nephrotic syndrome

Nephron - Clinical Practice

Volumn 110, Issue 1, 2008, Pages

  Karthikeyan, Kadirvel ^a   Sinha, Indrajit ^a   Prabhu, Krishnananda ^a   Bhaskaranand, Nalini ^a   Rao, Anjali ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Nephrotic syndrome; Plasma; Protein thiols; Total antioxidant power

Indexed keywords

ALBUMIN; PLASMA PROTEIN; PREDNISONE; THIOL;

ADOLESCENT; ALBUMIN BLOOD LEVEL; ANTIOXIDANT ACTIVITY; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE COURSE; DRUG DOSE REDUCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RELAPSE; REMISSION; SINGLE DRUG DOSE; SPECTROPHOTOMETRY; TREATMENT RESPONSE;

ADOLESCENT; ANTIOXIDANTS; BLOOD PROTEINS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GLUCOCORTICOIDS; HUMANS; INDIA; INFANT; MALE; NEPHROTIC SYNDROME; OXIDATIVE STRESS; PREDICTIVE VALUE OF TESTS; PREDNISONE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN; SPECTROPHOTOMETRY; SULFHYDRYL COMPOUNDS;

EID: 47949088815     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000148210     Document Type: Article

References (15)

1. Kamireddy R, Kavuri S, Devi S, Vemula H, Chandana D, Harinarayanan S, James R, Rao A: Oxidative stress in pediatric nephrotic syndrome. Clin Chim Acta 2002;325:147-150.
2. Kinra S, Rath B, Kabi BC: Indirect quantification of lipid peroxidation in steroid responsive nephrotic syndrome. Arch Dis Child 2000;82:76-78.
3. Balamurugan R, Bobby Z, Selvaraj N, Nalini P, Koner BC, Sen SK: Increased protein glycation in non-diabetic pediatric nephrotic syndrome: possible role of lipid peroxidation. Clin Chim Acta 2003;337:127-132.
4. Matsumoto K, Osakabe K, Katayama H, Okano K, Hatano M: Defective cell mediated immunity in lipoid nephrosis. Int Arch Allergy Appl Immunol 1984;73:370-372.
5. Chan MK, Chan KW, Jones B: Immunoglobulins (IgG, IgA, IgM, IgE) and complement complements (C3, C4) in nephrotic syndrome due to minimal change and other forms of glomerulonephritis, a clue for steroid therapy? Nephron 1987;47:125-130.
6. Fiser RT, Arnold WC, Charlton RK, Steele RW, Childress SH, Shirkey B: T-lymphocyte subsets in nephrotic syndrome. Kidney Int 1991;40:913-916.
7. Benzie IF, Strain JJ: Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol 1999;299:15-27.
8. Motchnik PA, Frei B, Ames BN: Measurement of antioxidants in human blood plasma. Methods Enzymol 1994;234:269-279.
9. Hu ML: Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 1994;233:380-385.
10. Sinha I, Ghosh S, Dey P, Jacob J, Banerjee D: Reduction of urinary thiols in nephrotic syndrome - a possible effect of free iron. Clin Chim Acta. 2005;355:91-96.
11. Cao G, Prior RL: Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem 1998;44:1309-1315.
12. Ece A, Atamer Y, Gurkan F, Davutoglu M, Kocyigit Y, Tutanc M: Paraoxonase, total antioxidant response, and peroxide levels in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 2005;20:1279-1284.
13. 2-isoprostanes and plasma antioxidant potential. Nephrol Dial Transplant 2001;16:1626-1630.
14. Kawamura T, Yoshioka T, Bills T, Fogo A, Ichikawa I: Glucocorticoid activates glomerular antioxidant enymes and protects glomeruli from oxidant injuries. Kidney Int 1991;40:291-301.
15. Thomas JA, Chai YC, Jung CH: Protein Sthiolation and dethiolation. Methods Enzymol 1994;233:385-395.